(Q37854871)

24 August 2017

title

Comprehensive analysis of Human Papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma (English)

1 reference

24 August 2017

main subject

Chlamydia trachomatis

0 references

1 reference

1 reference

Koen D Quint

1

1 reference

24 August 2017

Maurits N C de Koning

2

1 reference

24 August 2017

Daan T Geraets

3

1 reference

24 August 2017

Wim G V Quint

4

1 reference

24 August 2017

Edyta C Pirog

5

1 reference

24 August 2017

language of work or name

English

0 references

publication date

5 June 2009

1 reference

24 August 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Gynecologic Oncology

1 reference

24 August 2017

volume

114

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

390-394

1 reference

maintained by WikiProject

24 August 2017

WikiProject Invasion Biology

0 references

cites work

Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Chlamydia trachomatis infection and persistence of human papillomavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

A highly sensitive, multiplex broad-spectrum PCR-DNA-enzyme immunoassay and reverse hybridization assay for rapid detection and identification of Chlamydia trachomatis serovars

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Herpes simplex virus type 2 and Chlamydia trachomatis in adenocarcinoma of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Absence of human papillomavirus infection in minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Prevalence of human papillomavirus types 16 and 18 in cervical adenocarcinoma and its precursors in Scottish patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Differences in HPV 16- and HPV 18 E6/E7 oncogene expression between in situ and invasive adenocarcinomas of the cervix uteri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Glandular lesions of the uterine cervix: prognostic implications of human papillomavirus status.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

The human papillomavirus status of invasive cervical adenocarcinoma: a clinicopathological and outcome analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Frequency and outcome of cervical cancer prevention failures in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

Human papillomavirus vaccines and the potential for cross-protection between related HPV types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2009.05.013

1 reference

24 August 2017

1 reference